ONC 10-Q: SEC filing
BeOne Medicines Ltd.
Filed with the SEC on · accession 0001628280-26-070477
ONC filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. BeOne Medicines Ltd. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including revenue, expenses, and balance sheet data.
Summary of the filing
BeOne Medicines Ltd. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including revenue, expenses, and balance sheet data. The filing contains standard XBRL-tagged financial statement data with no single discrete corporate event disclosed.
Key details
✦ Ask GOAX AI about this filing — what it means for ONC, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ONC?
Click hereFrequently asked questions
What did ONC file with the SEC on Nov 5, 2026?
ONC filed a 10-Q (SEC filing). BeOne Medicines Ltd. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including revenue, expenses, and balance sheet data. The filing contains standard XBRL-tagged financial statement data with no single discrete corporate event disclosed.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Other ONC SEC filings
- 8-K · SEC filingAug 26, 2026
- 10-Q · SEC filingAug 5, 2026
- 8-K · SEC filingAug 5, 2026
- 144 · Insider sale plannedJul 10, 2026
- 144 · Insider sale plannedJul 10, 2026
- 8-K · Regulatory actionJun 26, 2026
- 8-K · SEC filingJun 11, 2026
- 8-K · Fda approvalMay 15, 2026
- 8-K · SEC filingMay 6, 2026
- 10-Q · SEC filingMay 6, 2026
Get alerts when ONC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days